We are live on ! Find out more
IRMD icon

iRadimed

119 hedge funds and large institutions have $310M invested in iRadimed in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

284% more call options, than puts

Call options by funds: $399K | Put options by funds: $104K

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

43% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 37

15% more capital invested

Capital invested by funds: $271M → $310M (+$39.4M)

5% more funds holding

Funds holding: 113119 (+6)

3.57% more ownership

Funds ownership: 48.23%51.8% (+3.6%)

Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
1.73%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
13
Increased
53
Reduced
37
Closed
7
Calls
$399K
Puts
$104K
Net Calls
+$295K
Net Calls Change
+$295K
Name Holding Trade Value Shares
Change
Change in
Stake
NTCM
1
Nine Ten Capital Management
Illinois
$37.9M +$1.18M +28,055 +4%
BlackRock
2
BlackRock
New York
$30.9M +$1.61M +38,275 +6%
SCM
3
Soleus Capital Management
Connecticut
$30.5M +$631K +15,000 +2%
Renaissance Technologies
4
Renaissance Technologies
New York
$27.5M +$223K +5,300 +0.9%
Vanguard Group
5
Vanguard Group
Pennsylvania
$20.3M +$619K +14,724 +4%
RCMC
6
RK Capital Management (Colorado)
Colorado
$16.2M +$1.66M +39,600 +13%
BCM
7
Bares Capital Management
Texas
$13.1M
RIM
8
Ranger Investment Management
Texas
$10.6M +$482K +11,465 +5%
Russell Investments Group
9
Russell Investments Group
United Kingdom
$10M +$198K +4,715 +2%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$10M +$93.4K +2,221 +1%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$8.38M -$217K -5,156 -3%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$7.51M +$375K +8,911 +6%
State Street
13
State Street
Massachusetts
$7.2M +$642K +15,273 +11%
Morgan Stanley
14
Morgan Stanley
New York
$6.89M +$3.86M +91,815 +172%
RCG
15
Resource Consulting Group
Florida
$4.89M +$4.33M +103,000 New
Millennium Management
16
Millennium Management
New York
$4.88M +$655K +15,577 +18%
HIM
17
Hillsdale Investment Management
Ontario, Canada
$4.26M -$12.2K -290 -0.3%
Northern Trust
18
Northern Trust
Illinois
$4.06M +$88.3K +2,101 +3%
RHJA
19
Rice Hall James & Associates
California
$3.65M -$26.4K -629 -0.8%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$2.66M +$20.6K +491 +0.9%
Goldman Sachs
21
Goldman Sachs
New York
$2.57M -$83.8K -1,993 -4%
Los Angeles Capital Management
22
Los Angeles Capital Management
California
$2.53M
Janus Henderson Group
23
Janus Henderson Group
United Kingdom
$1.86M +$457K +10,874 +38%
BAM
24
Ballast Asset Management
Texas
$1.72M +$468K +11,136 +44%
Calamos Advisors
25
Calamos Advisors
Illinois
$1.67M -$30.9K -735 -2%

IRMD Hedge Fund Activity: Q4 2023 in Review

119 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2023, worth a combined $310M — up 15% from $271M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new IRMD positions and 7 closed out — a net gain of 6 holders — while 53 added to existing stakes and 37 trimmed.

The largest buyer was Resource Consulting Group, opening a new position worth an estimated $4.33M. The largest seller was EAM Investors, exiting entirely with an estimated $909K sold.

  • 119 institutional investors held iRadimed (IRMD) as of Q4 2023, up from 113 in Q3 2023.
  • Funds reported $310M of iRadimed stock for Q4 2023, up 15% quarter-over-quarter.
  • 13 funds opened new iRadimed positions in Q4 2023 and 7 closed out, a net change of +6 holders.
  • The largest iRadimed buyer in Q4 2023 was Resource Consulting Group, an estimated $4.33M added.
  • The largest iRadimed seller in Q4 2023 was EAM Investors, an estimated $909K sold.

Based on aggregated 13F filings for Q4 2023.